PT  - JOURNAL ARTICLE
AU  - de Moraes, Fernanda Hansen Pacheco
AU  - Sudo, Felipe
AU  - Monteiro, Marina Carneiro
AU  - de Melo, Bruno R. P.
AU  - Mattos, Paulo
AU  - Mota, Bruno
AU  - Tovar-Moll, Fernanda
TI  - Independent morphological variables correlate with Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
AID  - 10.1101/2022.01.10.22268812
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.10.22268812
4099  - http://medrxiv.org/content/early/2022/01/12/2022.01.10.22268812.short
4100  - http://medrxiv.org/content/early/2022/01/12/2022.01.10.22268812.full
AB  - This manuscript presents a study with recruited volunteers that comprehends three sorts of events present in Alzheimer’s Disease (AD) evolution (structural, biochemical, and cognitive) to propose an update in neurodegeneration biomarkers for AD. The novel variables, K, I, and S, suggested based on physics properties and empirical evidence, are defined by power-law relations between cortical thickness, exposed and total area, and natural descriptors of brain morphology. Our central hypothesis is that variable K, almost constant in healthy human subjects, is a better discriminator of a diseased brain than the current morphological biomarker, Cortical Thickness, due to its aggregated information. We extracted morphological features from 3T MRI T1w images of 123 elderly subjects: 77 Healthy Cognitive Unimpaired Controls (CTL), 33 Mild Cognitive Impairment (MCI) patients, and 13 Alzheimer’s Disease (AD) patients. Moreover, Cerebrospinal Fluid (CSF) biomarkers and clinical data scores were correlated with K, intending to characterize health and disease in the cortex with morphological criteria and cognitive-behavioral profiles. K distinguishes Alzheimer’s Disease, Mild Cognitive Impairment, and Healthy Cognitive Unimpaired Controls globally and locally with reasonable accuracy (CTL-AD, 0.82; CTL-MCI, 0.58). Correlations were found between global and local K associated with clinical behavioral data (executive function and memory assessments) and CSF biomarkers (t-Tau, Aβ-40, and Aβ-42). The results suggest that the cortical folding component, K, is a premature discriminator of healthy aging, Mild Cognitive Impairment, and Alzheimer’s Disease, with significant differences within diagnostics. Despite the non-concomitant events, we found correlations between brain structural degeneration (K), cognitive tasks, and biochemical markers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Research Support Foundation of the State of Rio de Janeiro (FAPERJ), National Council for Scientific and Technological Development (CNPq), and intramural grants from Instituto DOr de Pesquisa e Ensino (IDOR). Bruno Mota is supported by Fundação Serrapilheira Institute (grant Serra-1709-16981) and CNPq (PQ 2017 312837/2017-8). We are thankful to the research team and volunteers for participating in this research project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Hospital Copa DOr Research Ethics Committee approved the present research under protocol number CAAE 47163715.0.0000.5249.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData acquired at IDOR does not have clearance for public sharing patients information that could lead to identification due to local Ethics Committee approval restrictions. Processed structural MRI images from the AHEAD and AOMIC datasets are available at open repository. https://doi.org/10.5281/zenodo.5750618